Merck
CN
Search Within
文件类型

112-48-1

应用筛选条件
关键词:'112-48-1'
显示 31-60 共 226 条结果 关于 "112-48-1" 范围 技术文档
XP725 Antibody Number-Lot Number 071M4826
173 174 175 176 2.3 105 106 107 108 129 130 131 132 153 154 155 156 177 178 179 180 2.4 109 110 111 112 133 134 135 136 157 158 159 160 181 182 183 184 2.5 113 114 115 116
The Effective Use of Protein Kinase Inhibitors
50 30 22 1 95 59 6 72 36 93 84 94 14 26 90 101 82 61 48 75 38 99 86 8 6 54 66 10 83 105 106 103 99 98 103 104 101 67
Periodic Table of the Elements - Certipur ICP / AAS standards
.91 1964 3695 1.45Rh 0, 1, 2, 3, 4, 5 [Kr] 4d85s1 46 106.42 1554.9 2963 1.30Pd 0, 2, 4 [Kr] 4d10 47 107.87 961.78 2162 1.42Ag 1, 2 [Kr] 4d105s1 48 112.41 321.07
Periodensystem der Elemente / Periodic table of Elements
.91 1964 3695 1.45Rh 0, 1, 2, 3, 4, 5 [Kr] 4d85s1 46 106.42 1554.9 2963 1.30Pd 0, 2, 4 [Kr] 4d10 47 107.87 961.78 2162 1.42Ag 1, 2 [Kr] 4d105s1 48 112.41 321.07
TRAPeze® Telomerase Detection Kit
dNTP Mix (Part Number 90406) 2.5 mM each dATP, dTTP, dGTP and dCTP 112 μL -15°C to -25°C TS Primer (Part Number 90407) 112 μL -15°C to -25°C Serially diluted extracts of telomerase-positive
GR 144053- Non-peptide antagonist of the platelet glycoprotein IIb/IIIa (GP IIb/IIIa) fibrinogen receptor
et al., J. Cell Sci., 111, 2445-2453 (1998). 111. Jinno, S., et al., EMBO J., 13, 1549-1556 (1994). 112. Galaktionov, K., et al., Science, 269, 1575-1577 (1995). 113 Ma, Z.Q., et al., Oncogene, 18, 4564-
Product Information Sheet-11582950001
Information 01 21 .1 15 83 48 40 01 7 Roche Diagnostics GmbH Sandhofer Strasse 116 68305 Mannheim Germany 5. Supplementary Information 01 21 .1 15 83 48 40 01 7 5.4.
Product Information Sheet - S1638
Smad4 Transcription Factors”). Université Pierre et Marie Curie, Paris VI, Ph.D. dissertation, p. 112 (2014). 35. Ng, Fu Liang, “The Impact of the Blood Pressure-Associated Genetic Locus at SLC4A7
Bio-Estapor microspheres
Sciences, Vol. 1109 (1), 493-502 6. Gemma De Las Cuevas and coll., (2008) Low-Gradient Magnetophoresis through Field-Induced Reversible Aggregation (2008) J. Phys. Chem. C., 112 (4), 945-950 7
Product Information Sheet - MAK183
mitochondrial gatekeeper pyruvate dehydrogenase in oncogene- induced senescence. Nature, 498(7452), 109–112 (2013). 4 Troubleshooting Guide Problem Possible Cause Suggested Solution Cold assay
Product Information Sheet - MAK189
., The alpha-ketoglutarate dehydrogenase complex in neurodegeneration. Neurochem. Int., 36(2), 97-112 (2000). 4 Troubleshooting Guide Problem Possible Cause Suggested Solution Cold assay
User Guide - Y04T-04-5PK
or 112 L gas cylinders with a C10 connection) 1 CAX2-ABR00 CellASIC® ONIX2 Microfluidic Services CellASIC® ONIX2 Essential Service Plan 1 CAX2-ESVC CellASIC® ONIX2 Total Service Plan 1 CAX2
Protein Tyrosine Phosphatases- Potential Roles in Disease
Table 1. Summary of Protein Tyrosine Phosphatases and possible disease associations. PTP Disease References PTP1B, LAR, SHIP-2 Diabetes 65-69 PTPα, KAP, cdc25, FAP1, Cancer 18-48, SHP-1, SHP-
CAS9PL - Product Information Sheet
RNP into immortalized and primary cells are as follows: 1. Preparation of cells. Plate cells in complete growth medium approximately 18–48 hours before use, depending on cell types. For most cell
Millicell -Angiogenesis Inhibition Assay
aliquots at -20 °C for up to 1 month. 4. D, L-Sulforaphane (Part No. CS203032) is provided as 1 mg lyophilized powder. To prepare a 50 mM Stock Solution, dissolve powder in 112 µL sterile
Periodic table Poster
3695 1.45 Rh 0, 1, 2, 3, 4, 5 [Kr] 4d85s1 46 106.42 1554.8 2963 1.30 Pd 0, 2, 4 [Kr] 4d10 47 107.87 961.78 2162 1.42 Ag 1, 2
Periodic table A4
3695 1.45 Rh 0, 1, 2, 3, 4, 5 [Kr] 4d85s1 46 106.42 1554.8 2963 1.30 Pd 0, 2, 4 [Kr] 4d10 47 107.87 961.78 2162 1.42 Ag 1, 2
Data Sheet - 74188
375 mU (13)GalT and 45 U alkaline phosphatase for 48 h. Finally, the products are isolated chromatographically from the turbid mixtures. Yields range from 40-70 %. 1.4. References 1 E.J. Toone
FlowCellect™ Mouse Th1 Differentiation Tool Kit
Re-Stimulation Reagent: (Part No.CS206520) One vial containing 48 μL cocktail of PMA and ionomycin in DMSO Materials Not Supplied 1. Mouse CD4+ enriched splenocytes 2. 24-well tissue culture
Product Information Sheet - MPAA3
43 1 3 3 3 Protein Kinase Cβ1 44 1 3 3 4 Protein Kinase Cβ1 45 1 3 4 1 Protein Kinase Cδ 46 1 3 4 2 Protein Kinase Cδ 47 1 3 4 3 BSA 48 1 3
Evaluation of Methods for Removal of Highly Abundant Human Plasma Proteins
43 10 Complement component 4B 112 59 Complement factor B 55 29 2 2 Plasma retinol-binding protein 6 3 Ceruloplasmin (Ferroxidase) 81 43 11 7 Alpha-1-antichymotrypsin 1 1 10 7 123 13 vitamin D-binding protein
PSEN1-RFP Alzheimer¿s Lentivirus
not sorted. References 1. Ryan NS, Rossor MN (2010) Correlating familial Alzheimer’s disease gene mutations with clinical phenotype. Biomark Med. 4(1): 99-112. 2. D’Avanzo C, Aronson J, Kim
APPSL-GFP Alzheimer¿s Lentivirus
not sorted. References 1. Ryan NS, Rossor MN (2010) Correlating familial Alzheimer’s disease gene mutations with clinical phenotype. Biomark Med. 4(1): 99-112. 2. D’Avanzo C, Aronson J, Kim
Data Sheet - G4510
by components of the abscisic acid pathway”. Universidade Nova de Lisboa, Ph.D. dissertation, p. 112 (2019). 40. Estabrooks, Samuel Kenneth, “Reconstitution of CFTR Ubiquitination and Endoplasmic
Nitrite Spectroquant Test Kits Method 2017
.135 Matrix Spike Percent Recovery 112 % 112% Matrix Spike Duplicate (NO2-N mg/L)) 0.138 0.135 Matrix Spike Duplicate Percent Recovery 108 % 112 % Relative Percent Difference 3.00
Validation and Qualification for Durapore® Sterilizing-Grade (0.22 µm) Membrane VMF4
13.4 6.98 114 32 15.2 >8.36 112 57 13.5 7.08 105 33 14.8 >8.36 116 44 14.2 7.29 104 34 15.6 >8.36 92 25 13.4 7.41 103 35 15.8 >8.36 95 36
Drug Discovery Products & Services - Volume 1, 2014
IV, active 14-547 3 CaM Kinase Iδ, active 14-731 3 CaMKK2, active 14-931 Casein Kinase 1, active, yeast 14-112 3 12-423, 12-529 Casein Kinase 1γ1, active 14-711 3 12-423, 12-529 Casein Kinase
Bioreactor Systems for Bone Tissue Engineering
mechanical stimulation (cyclic compres- sion)112 or online-monitoring of mineralization.110 Reported constant perfusion flow rates range from 199 to 600 mL/h.112 Flow rate levels exceeding a specific range
RQflex 10 - Manual
procedures 10 Test-method memory 11 Multifunctional display 12 CODE MEM SEC 1 8 12 7 9 10 112 3 4 5 2 6 1 3 4 5
59505 Galactosyltransferase Kit
-GlcNAc(14)-GlcNAc-OH  -Gal(14)--GlcNAc(14)-GlcNAc-OH 47,58 -GlcNAc(16)-Gal-OH  -Gal(14)--GlcNAc(16)-Gal-OH 38,54 -GlcNAc(13)-Gal-OH  -Gal(14)--GlcNAc(13)-Gal-OH 38,54
2/8